Featured Research

from universities, journals, and other organizations

Mutations Not The Only Gene Defect That Leads To Cancer

Date:
March 22, 2000
Source:
Ohio State University
Summary:
New research shows that gene mutations are not the only kinds of defects involved in the transformation of a healthy cell into a malignant one. Scientists say that this may mean the nature of cancer is even more complicated than once thought. Another kind of defect, one that turns off genes without changing their DNA, is also at work, and probably to a much greater degree than ever suspected.

COLUMBUS, Ohio -- New research shows that gene mutations are not the only kinds of defects involved in the transformation of a healthy cell into a malignant one. Scientists say that this may mean the nature of cancer is even more complicated than once thought.

Another kind of defect, one that turns off genes without changing their DNA, is also at work, and probably to a much greater degree than ever suspected.

The findings, published recently in the journal Nature Genetics, strongly suggest that an unknown number of genes - over and above those affected by mutations - are involved in the cancer process.

"Science has been studying changes and alterations at the genetic level in cancer cells, and we thought we understood tumor progression," said Christoph Plass, assistant professor of molecular virology, immunology, and molecular genetics at the Ohio State University Comprehensive Cancer Center.

"Now there is this second layer of complexity. A lot ofscientists are going to be kept very busy trying to understand this," said Plass, coordinator and one of the principal investigators of the study.

This type of gene defect involves a process known as DNA methylation. Normally, healthy cells use DNA methylation during development and throughout life to turn off genes that are not needed. In cancer cells, aberrant DNA methylation turns off genes that would normally prevent inappropriate cell division. In other words, it shuts down one of the body's best mechanisms that prevents a cell from becoming cancerous.

"This is the first time in which DNA methylation has been studied in human cancer on a scale this large and in which different tumor types have been compared."

The research presented several surprises.

"When we began this study, we expected to find methylation in a few key tumor suppressor genes," he said. "Nobody expected to find this high degree of methylation."

In fact, the researchers found that up to 10 percent of the genes in some tumors types were inactivated by methylation.

"This was surprising because it suggests that 4,000 to 5,000 genes might be deregulated (turned off) by aberrant DNA methylation in some types of tumors."

There were other surprises as well.

DNA methylation in cancer was discovered about 10 years ago and until now, people believed that its role in cancer was limited to inactivating tumor-suppressor genes.

"We were surprised to find that only 40 percent of the methylation events we detected involved changes in gene activation, while the other 60 percent did not," said Plass. "The genes represented by this 40 percent should be investigated for their relationship to cancer.

"The function of those genes whose activation remains unchanged by methylation is unclear, though, as are the consequences of this methylation for the cell. We believe that methylation may contribute to the overall genetic instability in the tumor." Genetic instability refers to the ease with which malignant cells can develop additional mutations.

The researchers also found that the pattern of methylation was very specific for some types of tumors.

"This aberrant methylation doesn't occur at random," he said. "In some tumor types - leukemia and head and neck cancer, for example - certain genes are methylated in very specific places, and we can use those sites as markers for certain tumor types."

Aberrant DNA methylation may therefore provide a way to identify subtypes of cancer that respond better to certain kinds of treatment.

Plass said there is also preliminary evidence suggesting that resistance to chemotherapy is in some cases linked to the degree of aberrant methylation in some tumors.

The study, conducted by Plass and a large team of researchers, examined 98 tumor samples to determine if any of the islands were methylated. The samples came from seven types of tumors: breast, colon, glioma, head and neck, leukemia, testicular, and primitive neuroectodermal tumors of childhood (PNET).

How DNA methylation turns off genes, and why it goes wrong in cancer cells is still unknown.


Story Source:

The above story is based on materials provided by Ohio State University. Note: Materials may be edited for content and length.


Cite This Page:

Ohio State University. "Mutations Not The Only Gene Defect That Leads To Cancer." ScienceDaily. ScienceDaily, 22 March 2000. <www.sciencedaily.com/releases/2000/03/000322091313.htm>.
Ohio State University. (2000, March 22). Mutations Not The Only Gene Defect That Leads To Cancer. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2000/03/000322091313.htm
Ohio State University. "Mutations Not The Only Gene Defect That Leads To Cancer." ScienceDaily. www.sciencedaily.com/releases/2000/03/000322091313.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins